N-n-propylnorapomorphine

Known as: N-propylnorapomorphine, n-propylapomorphine, 6-propylnorapomorphine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2014
02419732014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
UNLABELLED It has been demonstrated in vitro that the dopamine D(2) receptor has 2 interconvertible affinity states for… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PET measurements of stimulant-induced dopamine (DA) release are typically performed with antagonist radioligands that bind to… (More)
  • figure 1
  • figure 2
  • figure 3
  • table II
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
(-)-N-Propyl-norapomorphine (NPA) is a full dopamine (DA) D2 receptor agonist and [11C]NPA is a suitable radiotracer to image D2… (More)
Is this relevant?
2003
2003
The binding of radioligand agonists to dopamine receptors in living brain can be informative about the abundance of receptors… (More)
Is this relevant?
1995
1995
An in vitro receptor binding and in vivo microdialysis study was performed to further investigate the modulation of dopamine (DA… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1989
1989
Previous studies with (S)-(+)-N-n-propylnorapomorphine (NPA), an enantiomer of the potent dopaminergic agonist (R)-(-)-NPA… (More)
Is this relevant?
1986
1986
The novel substituted benzamide eticlopride, (S)-(-)-5-chloro-3-ethyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxy salicylamide… (More)
Is this relevant?
1985
1985
Rats were treated continuously for up to 20 months with either haloperidol (1.4–1.6 mg/kg/day), sulpiride (102–109 mg/kg/day) or… (More)
  • table 1
  • table 3
  • figure I
Is this relevant?
1976
1976
DOPAMINE has several unique actions in the central nervous system (CNS)—particularly the striatum—and in blood vessels, which… (More)
Is this relevant?